CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor
- PMID: 2214026
- PMCID: PMC248611
- DOI: 10.1128/JVI.64.11.5585-5593.1990
CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor
Abstract
We analyzed coexpression of the human immunodeficiency virus type 1 glycoprotein precursor, gp160, and its cellular receptor CD4 in HeLa cells to determine whether the two molecules can interact prior to transport to the cell surface. Results of studies employing coprecipitation, analysis of oligosaccharide processing, and immunocytochemistry showed that newly synthesized CD4 and gp160 form a complex prior to transport from the endoplasmic reticulum (ER). CD4 expressed by itself was transported efficiently from the ER to the cell surface, but the complex of CD4 and gp160 was retained in the ER. This retention of CD4 within the ER is probably a consequence of the very inefficient transport of gp160 itself (R. L. Willey, J. S. Bonifacino, B. J. Potts, M. A. Martin, and R. D. Klausner, Proc. Natl. Acad. Sci. USA 85:9580-9584, 1988). Retention of CD4 in the ER by gp160 may partially explain the down regulation of CD4 in human immunodeficiency virus type 1-infected T cells. Inhibition of CD4 transport appears to be a consequence of the interaction of two membrane-bound molecules, because a complex of CD4 and gp120 (the soluble extracellular domain of gp160) was transported rapidly and efficiently from the ER.
Similar articles
-
Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.J Gen Virol. 1993 Oct;74 ( Pt 10):2085-97. doi: 10.1099/0022-1317-74-10-2085. J Gen Virol. 1993. PMID: 8409933
-
Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.J Biochem. 1994 May;115(5):1010-20. doi: 10.1093/oxfordjournals.jbchem.a124414. J Biochem. 1994. PMID: 7961587
-
Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum.J Virol. 1992 Apr;66(4):2296-301. doi: 10.1128/JVI.66.4.2296-2301.1992. J Virol. 1992. PMID: 1548763 Free PMC article.
-
Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.J Virol. 1992 Jan;66(1):226-34. doi: 10.1128/JVI.66.1.226-234.1992. J Virol. 1992. PMID: 1727486 Free PMC article.
-
Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4.J Virol. 1992 Dec;66(12):7193-200. doi: 10.1128/JVI.66.12.7193-7200.1992. J Virol. 1992. PMID: 1433512 Free PMC article.
Cited by
-
Intracellular interaction of human immunodeficiency virus type 1 (ARV-2) envelope glycoprotein gp160 with CD4 blocks the movement and maturation of CD4 to the plasma membrane.J Virol. 1990 Dec;64(12):6297-304. doi: 10.1128/JVI.64.12.6297-6304.1990. J Virol. 1990. PMID: 2243395 Free PMC article.
-
Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.J Exp Med. 1992 Dec 1;176(6):1531-42. doi: 10.1084/jem.176.6.1531. J Exp Med. 1992. PMID: 1460417 Free PMC article. Clinical Trial.
-
Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens.J Virol. 2002 Jul;76(13):6425-34. doi: 10.1128/jvi.76.13.6425-6434.2002. J Virol. 2002. PMID: 12050354 Free PMC article.
-
Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.J Virol. 2000 Feb;74(4):1815-26. doi: 10.1128/jvi.74.4.1815-1826.2000. J Virol. 2000. PMID: 10644355 Free PMC article.
-
Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro.Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6395-9. doi: 10.1073/pnas.90.14.6395. Proc Natl Acad Sci U S A. 1993. PMID: 8341644 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials